Published 1 day ago • loading... • Updated 1 day ago

Advocacy Group Says a Medicare Rule Change Delayed Price Negotiation for a Costly AbbVie Drug by Seven Years

Public Citizen says a CMS eligibility change kept AbbVie's Creon out of Medicare price negotiation for seven extra years. Here is how it works.

Public Citizen says a CMS eligibility change kept AbbVie's Creon out of Medicare price negotiation for seven extra years. Here is how it works.

1 day ago

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Total News Sources1

Leaning Left0Leaning Right0Center1Last Updated1 day agoBias Distribution

100% Center

100% Center

To view factuality data please Upgrade to Premium

To view ownership data please Upgrade to Vantage

Medical Daily broke the news 1 day ago on Monday, August 10, 2026.

Sources are mostly out of (0)